Huai, Edward – Trademark Portfolio

Entity Type: 01

Huai, Edward holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 21 (Housewares) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include FLYBY. The owner is based in New York, NY.

254 Park Avenue South 8K

New York, NY 10010

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FLYBY
FLYBY
Registered 2020
FLYBY
FLYBY
Registered 2015

Trademark Classifications

Huai, Edward's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Huai, Edward have?

Huai, Edward has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.

What trademark classes does Huai, Edward file in?

Huai, Edward files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 21 (Housewares), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Huai, Edward's most well-known trademarks?

Huai, Edward's registered trademark portfolio includes well-known marks such as FLYBY. These are among 2 currently registered trademarks in the portfolio.

What is Huai, Edward's trademark registration success rate?

Huai, Edward has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.